In brief
An Australian‑led meta‑analysis of 61 studies shows current smokers have a 31% higher overall risk of dementia, 40% higher risk of Alzheimer’s disease and 52% higher risk of vascular dementia. The risk rises with cigarettes smoked per day, yet former smokers do not show elevated risk. Researchers urge that brain health be highlighted in anti‑smoking initiatives.
Current smokers face a markedly higher risk of developing dementia, a finding from a systematic review that pooled data on more than 2.8 million adults worldwide.
The analysis, led by researchers at Australia’s Curtin University and published in the journal eClinicalMedicine, examined 61 studies that included all‑cause dementia, Alzheimer’s disease and vascular dementia.
Those who still smoke are 31 percent more likely to develop dementia over their lifetimes. In specific forms, the odds increase to 40 percent for Alzheimer’s disease and 52 percent for vascular dementia, according to the study’s lead authors.
Risk also scales with the number of cigarettes consumed each day. Participants who smoked ten cigarettes a day had a 16 percent higher dementia risk compared with never‑smokers; the figure rises to 34 percent for those who smoke twenty a day.
Former smokers, however, did not show a higher dementia risk than people who had never smoked. This suggests that quitting may halt the incremental danger posed by ongoing tobacco use.
While the study cannot prove that smoking directly causes dementia, the patterns mirror long‑term observations linking tobacco exposure to cardiovascular and neurodegenerative disease.
Researchers from Curtin University emphasized that the findings strengthen the case for integrating brain‑health messages into anti‑smoking campaigns, cigarette package warnings, and cessation programmes.
“Our evidence suggests that quitting smoking could be an important part of reducing dementia risk,” said a study spokesperson, echoing the recommendation that public health messaging address cognitive outcomes alongside more familiar risks such as cancer and heart disease.
The meta‑analysis drew on data from low‑, middle‑ and high‑income countries, demonstrating that smoking’s influence on dementia risk is a global concern. The 61 studies spanned a wide geographic and demographic range, underscoring the consistency of the association across populations.
Producers of tobacco warnings now have a scientific basis for revising risk summaries to include dementia alongside the traditionally highlighted respiratory and cardiovascular hazards, a shift advocated by the authors.
In view of these results, public health initiatives might consider incorporating specific messaging about the impact of smoking on brain health in future communications, following a recommendation by the Curtin University study team.
Further research is expected to refine our understanding of how nicotine and other cigarette constituents influence neurodegenerative pathways, but the present analysis provides a comprehensive update to evidence accumulated over the past decade.
